Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP).
Pediatric Blood and Cancer.
Times cited: 36
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: Safety and efficacy.
British Journal of Haematology.
Times cited: 141
A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia.
Times cited: 138